Insider Selling: Strata Critical Medical (NASDAQ:SRTA) CEO Sells $185,908.77 in Stock

Strata Critical Medical (NASDAQ:SRTA) CEO William Heyburn sold 31,671 shares of the company’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $185,908.77. Following the transaction, the chief executive officer directly owned 1,548,997 shares of the company’s stock, valued at approximately $9,092,612.39. This trade represents a 2.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Trading Down 1.1%

Shares of NASDAQ:SRTA opened at $5.43 on Friday. The company has a market capitalization of $469.86 million, a P/E ratio of -67.88 and a beta of 2.20. The company’s 50-day moving average price is $5.22. Strata Critical Medical has a 12 month low of $3.57 and a 12 month high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.07. The firm had revenue of $67.38 million during the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. As a group, equities research analysts expect that Strata Critical Medical will post -0.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SRTA. B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. Zacks Research raised Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. Weiss Ratings upgraded Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. Finally, Craig Hallum assumed coverage on Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SRTA. Dimensional Fund Advisors LP grew its holdings in shares of Strata Critical Medical by 11.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after acquiring an additional 172,154 shares during the period. Principal Financial Group Inc. purchased a new position in shares of Strata Critical Medical during the 1st quarter worth approximately $537,000. Quantinno Capital Management LP grew its holdings in shares of Strata Critical Medical by 98.7% during the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares during the period. Bank of America Corp DE grew its holdings in Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after purchasing an additional 25,379 shares during the period. Finally, Granite Investment Partners LLC grew its holdings in Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after purchasing an additional 7,911 shares during the period. Hedge funds and other institutional investors own 47.36% of the company’s stock.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.